Latest News
Our latest research, company updates and industry insight
Parkinson’s and statins: PD-Monitor in clinical study
ClearSky’s PD-Monitor has been used in a nationwide study to investigate whether statins are effective in slowing the progress of Parkinson’s.
Global recognition for ClearSky Medical Diagnostics
ClearSky Medical Diagnostics is recognised as an ‘up and coming’ company tackling neurodegenerative disease through technology.
LID-Monitor to also ‘manage bradykinesia’ // China study
ClearSky has launched a new study in China to establish introducing bradykinesia as a feature being measured by LID-Monitor.
ClearSky presented at international innovation event MIT REAP
ClearSky’s Professor Stephen Smith hosted a stand at an innovation exchange event in Leeds in January – part of a prestigious international innovation programme that the city of Leeds was chosen to host with Massachusetts Institute of Technology (MIT).
Living with Parkinson’s: Using the LID-Monitor
John has Parkinson’s – in this blog he explains how using the LID-Monitor could help with managing when patients take their Levodopa medication.
LID-Monitors at Leeds Teaching Hospitals
ClearSky Medical Diagnostics is thrilled to announce that two LID-Monitors, designed to help people with Parkinson’s control their condition, have been acquired at a hospital in Leeds.
CF-Monitor to feature in MedGEC Workshop at GECCO 2019
Experimental work being undertaken in the development of ClearSky’s CF-Monitor will be presented at the MedGEC Workshop at GECCO 2019 in Prague in July.
ClearSky at Nanjing Tech Week
ClearSky will showcase its technology and products at an international summit of medical innovators at Nanjing Tech Week in China this week.
ClearSky & Shimmer transform wearables data into actionable insights
ClearSky Medical Diagnostics has forged a partnership with Shimmer Research – a leading provider of wearable wireless sensing solutions – to bring a new level of analytic capabilities to the use of wearable sensors in clinical research.
ClearSky heads to Parkinson’s Congress in Nice
The ClearSky Medical Diagnostics team will be attending the 23rd International Congress of Parkinson’s Disease and Movement Disorders (MDS) in September 2019.
‘Lifesaver’ Smith recognised for Parkinson’s research
Professor Stephen Smith has been hailed a ‘national lifesaver’ in recognition of his research into the diagnosis and treatment of Parkinson’s. Smith - ClearSky's co-founder and director - and his research team at University of York, have been placed on the MadeAtUni...
Team hosts stand at Edinburgh HIT Research Festival
The ClearSky MD team headed to the HIT (Health innovation and Technologies) Research Festival at Heriot-Watt university in Edinburgh at the start of April.